| Product NDC: | 55154-6662 |
| Proprietary Name: | PENTOXIFYLLINE |
| Non Proprietary Name: | PENTOXIFYLLINE |
| Active Ingredient(s): | 400 mg/1 & nbsp; PENTOXIFYLLINE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-6662 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075191 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19990610 |
| Package NDC: | 55154-6662-9 |
| Package Description: | 6 BLISTER PACK in 1 CARTON (55154-6662-9) > 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
| NDC Code | 55154-6662-9 |
| Proprietary Name | PENTOXIFYLLINE |
| Package Description | 6 BLISTER PACK in 1 CARTON (55154-6662-9) > 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
| Product NDC | 55154-6662 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PENTOXIFYLLINE |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19990610 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | PENTOXIFYLLINE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |